Skip to content

Download our latest eBook on lung airway epithelial cell and fibroblast models

Updates: Company News

6th March, 2024

Biotech firm raises £2.3m for lab models that help avoid animal testing

The Newcastle-based company has secured funding from existing investors including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds…

Read update
Newcells Biotech
21st March, 2023

Newcells Biotech collaborates with consortium in Eurostars funded project to advance novel therapy for Alpha-1 Antitrypsin (AAT) Deficiency

The Eurostars grant of €1.2m will support the partners, led by Gain, and includes Newcells, the Institute for Research in Biomedicine (Lausanne) and the University of Helsinki.  Newcells will…

Read update
A cropped image of the Newcells team wearing festive jumpers
9th December, 2022

Newcells team support charity with festive jumpers

Thursday 8th December 2022 was Christmas Jumper Day in the UK to raise money for the charity Save the Children. A prize was given for the…

Read update
Three men wearing matching t-shirts
24th November, 2022

NB staff supports Motor Neurone Disease Charity

Having become engaged (now married!) in the summer of 2021, Will’s thoughts turned to arrangements for his stag party. Rather than take the traditional route Will hatched a plan…

Read update
Dr Kathryn Garner, PhD
17th January, 2022

Dr Kathryn Garner, Head of Kidney Development at NB

As she narrates her story, you have the impression that you have made the journey with her, her words becoming rich images in…

Read update
Thought Leadership workshop hosted by Newcells Biotech
18th August, 2021

Thought Leadership Workshop hosted by NB: Emerging in vitro technologies for gene therapy applications

These include the first oligonucleotide-based therapies (Spinraza, Exondys, Vyondys), in vivo gene therapies (Luxturna and Zolgensma) and the first cell therapies (Kymriah, Yescarta, Tescartus). Such novel therapeutics treat disorders varying…

Read update
29th August, 2023

Latest Advances in CAR-T Therapy with novel HLA-typed in vitro cell tools

CAR-T Therapy CAR-T Therapy is a form of immunotherapy that harnesses the power of the patient’s immune system to target and eliminate cancer cells. It involves ex-vivo genetic engineering of…

Read update
28th July, 2023

MPS summit highlights

About the conference: MPS summit The MPS summit is a small but buzzing conference, where scientists from the pharma industry, academia and microchip manufacturers gather to discuss the latest advances…

Read update
30th June, 2023

3rd ILD Summit Highlights

About the conference : ILD Summit The ILD Summit is a niche industry dedicated conference focussed on advancing therapies for progressive fibrosing interstitial lung diseases (ILD). This year’s conference was the…

Read update
Pulmonary toxicity – a challenge for drug and chemical development
16th June, 2023

Pulmonary toxicity – a challenge for drug development

Despite the common assumption that adverse drug reactions usually affect the kidney and liver, over 600 medications have been reported to induce lung toxicity.1 Due to ehri large surface area,…

Read update
5th May, 2023

ARVO Highlights

About the conference: ARVO The ARVO conference took place in the New Orleans Ernest N. Morial Convention Center.  With over 10 000 attendees, the venue was absolutely huge. If you…

Read update
iPSC-derived retinal pigment epithelial (RPE) cells
28th April, 2023

Latest innovation in retina models brings a fully characterised Retina Pigment Epithelium (RPE)

Why develop an RPE model? Retinal pigment epithelium (RPE) cells play a vital role in the retina by forming the outer blood-retinal barrier and maintaining photoreceptor and visual…

Read update

Get our latest updates straight to your inbox